epirubicin has been researched along with Angiosarcoma in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (50.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahari, A; Chawla, SP; Chua, V; Krkyan, N; Moradkhani, A; Osada, A; Riedel, RF | 1 |
| Davies, H; Jiang, L; Shi, K; Xu, X | 1 |
| Cheng, SJ; Chu, JS; Kuo, CY; Lee, KD; Lin, SH; Tu, SH | 1 |
| Bai, B; Cui, Y; Lu, C; Luo, Z | 1 |
| Chang, W; Chen, J; Deng, R; Tao, K; Wu, X; Zhang, P | 1 |
| Rihova, B | 1 |
| Etrych, T; Jelínková, M; Kovár, M; Kubácková, K; Mrkvan, T; Plocová, D; Pokorná, J; Ríhová, B; Rozprimová, L; Sírová, M; Strohalm, J; Ulbrich, K | 1 |
| Canney, P; Evans, V; Fraser, G; Gray, M; Kazmi, A; Kerr, J; Mano, MS | 1 |
| Gall, TT; Kim, SE; Liptak, JM; Monteith, GJ; Woods, JP | 1 |
| Amato, L; Fabbri, P; Franchi, A; Gallerani, I; Moretti, S; Palleschi, GM | 1 |
2 review(s) available for epirubicin and Angiosarcoma
| Article | Year |
|---|---|
Primary splenic angiosarcoma with fever and anemia: a case report and literature review.
Topics: Anemia; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy; Chemotherapy, Adjuvant; Epirubicin; Fever; Hemangiosarcoma; Humans; Ifosfamide; Immunohistochemistry; Laparoscopy; Male; Middle Aged; Splenectomy; Splenic Neoplasms; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
Drug-HPMA-HuIg conjugates effective against human solid cancer.
Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Agents; Breast Neoplasms; Doxorubicin; Epirubicin; Female; Heart Neoplasms; Heart Transplantation; Hemangiosarcoma; Hempa; Humans; Immunoglobulin G; Immunotherapy; Lymphatic Metastasis; Middle Aged; Neoplasms | 2003 |
1 trial(s) available for epirubicin and Angiosarcoma
| Article | Year |
|---|---|
Results of NC-6300 (Nanoparticle Epirubicin) in an Expansion Cohort of Patients with Angiosarcoma.
Topics: Anthracyclines; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Hemangiosarcoma; Humans; Micelles; Nanoparticles; Neutropenia; Polymers; Proteins; Thrombocytopenia | 2022 |
7 other study(ies) available for epirubicin and Angiosarcoma
| Article | Year |
|---|---|
The effect of ifosfamide, epirubicin, and recombinant human endostatin therapy on a cardiac angiosarcoma: A case report.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Endostatins; Epirubicin; Heart Neoplasms; Hemangiosarcoma; Humans; Ifosfamide; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Recombinant Proteins | 2019 |
Transcatheter arterial chemoembolization improves the resectability of malignant breast phyllodes tumor with angiosarcoma component: a case report.
Topics: Antineoplastic Agents; Breast Neoplasms; Chemoembolization, Therapeutic; Chemotherapy, Adjuvant; Drug Administration Schedule; Epirubicin; Female; Hemangiosarcoma; Humans; Mastectomy; Middle Aged; Neoadjuvant Therapy; Neoplasms, Complex and Mixed; Phyllodes Tumor | 2019 |
[Feasibility analysis of endostatin combined with chemotherapy in the treatment of metastatic angiosarcoma].
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Docetaxel; Endostatins; Epirubicin; Feasibility Studies; Female; Follow-Up Studies; Hemangiosarcoma; Humans; Liver Neoplasms; Male; Middle Aged; Pubic Bone; Taxoids | 2014 |
Clinical experience with anthracycline antibiotics-HPMA copolymer-human immunoglobulin conjugates.
Topics: Acrylamides; Adult; Animals; Antibiotics, Antineoplastic; Biomarkers, Tumor; Breast Neoplasms; Doxorubicin; Drug Carriers; Drug Delivery Systems; Drug Resistance, Neoplasm; Epirubicin; Female; Hemangiosarcoma; Humans; Immunoglobulin G; Immunoglobulins, Intravenous; Immunologic Factors; Middle Aged; Neoplasm Metastasis; Polymethacrylic Acids; Quality of Life; Treatment Outcome | 2009 |
Radiation-induced angiosarcoma of the breast shows major response to docetaxel after failure of anthracycline-based chemotherapy.
Topics: Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Docetaxel; Drug Resistance, Neoplasm; Epirubicin; Female; Fluorouracil; Hemangiosarcoma; Humans; Neoplasms, Radiation-Induced; Taxoids; Treatment Outcome | 2006 |
Epirubicin in the adjuvant treatment of splenic hemangiosarcoma in dogs: 59 cases (1997-2004).
Topics: Animals; Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Dog Diseases; Dogs; Epirubicin; Female; Hemangiosarcoma; Male; Prognosis; Retrospective Studies; Splenectomy; Splenic Neoplasms; Survival Analysis; Time Factors; Treatment Outcome | 2007 |
A case of angiosarcoma of the face successfully treated with combined chemotherapy and radiotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Facial Neoplasms; Hemangiosarcoma; Humans; Ifosfamide; Male; Radiotherapy, Adjuvant; Skin Neoplasms | 2000 |